Switching to Once-Daily Insulin Degludec/Insulin Aspart from Basal Insulin Improves Postprandial Glycemia in Patients with Type 2 Diabetes Mellitus: Randomized Controlled Trial

BACKGROUND: To explore the efficacy and safety of switching from once-daily basal insulin therapy to once-daily pre-meal injection insulin degludec/insulin aspart (IDegAsp) with respect to the glycemic control of participants with type 2 diabetes mellitus (T2DM). METHODS: In this multicenter, open-l...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Kyu Yong, Nakamura, Akinobu, Oba-Yamamoto, Chiho, Tsuchida, Kazuhisa, Yanagiya, Shingo, Manda, Naoki, Kurihara, Yoshio, Aoki, Shin, Atsumi, Tatsuya, Miyoshi, Hideaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7453982/
https://www.ncbi.nlm.nih.gov/pubmed/31769240
http://dx.doi.org/10.4093/dmj.2019.0093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7453982/
https://www.ncbi.nlm.nih.gov/pubmed/31769240
http://dx.doi.org/10.4093/dmj.2019.0093

Ejemplares similares